- Canadian neurosurgeons, in partnership with Elon Musk's Neuralink, are recruiting six patients with quadriplegia for a brain implant study.
- The CAN-PRIME trial will test the safety and efficacy of Neuralink's device, which allows users to control devices with their thoughts.
- The study will be conducted at Toronto's University Health Network, with surgeries performed by a multidisciplinary team.
Share

